Canadian EdoxAban (Lixiana®) Registry in Patients With ATrial Fibrillation and/or ATrial Flutter With Confirmed ValvUlar HeaRt DiseasE (CAPTURE)
Phase of Trial: Phase IV
Latest Information Update: 23 Oct 2019
Price : $35 *
At a glance
- Drugs Edoxaban (Primary)
- Indications Atrial fibrillation; Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms CAPTURE
- 09 Jul 2019 Status changed from not yet recruiting to recruiting.
- 16 May 2019 Planned initiation date changed from 1 Apr 2019 to 1 Jun 2019.
- 11 Mar 2019 Planned initiation date changed from 1 Jan 2019 to 1 Apr 2019.